SHENYANG, China, Jan. 18, 2016 /PRNewswire/ -- Neusoft Medical Systems Co., Ltd. ("Neusoft Medical Systems") officially launched the NeuSight PET/CT for global markets. This CE certified & US FDA approved NeuSight PET/CT combines leading-edge technologies and innovations to create super-fine and low dose exquisite images, which can provide more accurate diagnostic information. The NeuSight PET/CT demonstrates the Company's determination to explore the international high-end PET/CT markets through innovations.
Previously, Neusoft Medical Systems collaborated with 'Positron', a cardiac PET pioneer in the USA. Now, Positron is fully owned by Neusoft, with more than 20 PET installations in the USA alone. By combining the technology know-how of Neusoft & Positron, the NeuSight PET/CT was successfully developed. The R&D for the NeuSight scanner started in 2012 with 4 PET/CT prototypes passing factory verification in 2014. In 2015, NeuSight PET/CT passed CE certification and was approved by US FDA.
The NeuSight PET/CT is equipped with high-end electronics that offer high quality diagnostic images with fastest acquisition and post processing speeds, thereby providing radiologists/nuclear medicine specialists with high throughput and a positive return on investment, as well as maintaining a dedication to keeping patient safety the top priority.
Mr. Patrick Wu, CEO of Neusoft Medical Systems said, "As a leading medical equipment provider, Neusoft Medical Systems set software technology as our core. We have continuously contributing software and product engineering innovation to China's medical industry for more than 20 years. The launch of NeuSight PET/CT is a new breakthrough for Neusoft in high-end medical equipment. Looking forward, we will make great efforts in innovation and operational excellence to offer high-quality medical products and services worldwide."
About Neusoft Medical Systems
Neusoft Medical Systems Co., Ltd. (Neusoft Medical Systems), a leading provider of medical equipment and service from China. Founded in 1998 and with software development as its core competency, Neusoft Medical Systems has become China's market leader in medical equipment and service and has expanded its leadership with the establishment of international subsidiaries in the United States of America, United Arab Emirates, Peru, Russia, Brazil, and Vietnam. It provides a wide portfolio of medical equipments, including CT, MRI, X-ray, Ultrasound, PET/CT, Linear Accelerator, and IVD (In Vitro Diagnostic Products). For more information, please visit: medical.neusoft.com/en
For more information, please contact:
Branding & Marketing Management Center
SOURCE Neusoft Corporation